As part of the 9th LuCE Report, Lung Cancer Europe (LuCE) has published a series of reports based on the 2024 survey: Empowering Voices: Knowledge and Decision-Making Among People Impacted by Lung Cancer in Europe.

These reports highlight key challenges and experiences shared by people affected by lung cancer across Europe. They offer valuable insights to help improve awareness, support, and care at both national and European levels.

What’s Included:

• 14 Country Reports: Covering responses from Croatia, Hungary, Italy, Germany, Ukraine, Finland, the UK, the Netherlands, Denmark, Greece, Spain, and France. Each report is available in the country’s national language and compares local data with European averages.

• Oncogene-Driven Lung Cancer Report: Focused on participants with specific oncogene drivers such as ALK, EGFR, KRAS, PD-L1, and ROS1.

• ALK-Positive UK Report: A special report supported by ALK Positive UK, highlighting experiences of people in the UK living with ALK-positive lung cancer.

These reports are a valuable tool for patients, advocates, healthcare professionals, and policymakers.

Access the Reports Below: